Creative Planning Cara Therapeutics, Inc. Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$18.28 - $26.91 $175,853 - $258,874	-9,620 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$17.68 - $21.57 $170,081 - $207,503	9,620 New	9,620 $207,000
Q4 2018 Feb 01, 2019	SELL	$12.45 - $23.47 $107,418 - $202,499	-8,628 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$17.57 - $23.95 $151,593 - $206,640	8,628 New	8,628 $207,000
Q1 2018 Apr 18, 2018	SELL	$11.77 - $16.08 $275,629 - $376,561	-23,418 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$11.86 - $14.08 $36,671 - $43,535	-3,092 Reduced 11.66%	23,418 $287,000
Q3 2017 Oct 17, 2017	BUY	$12.6 - $16.34 $334,026 - $433,173	26,510	26,510 $363,000

12.7M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $264M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.